All of the following decreases cerebral blood now, and intracninial pressure except:
**Core Concept**
The regulation of cerebral blood flow (CBF) and intracranial pressure (ICP) is crucial for maintaining optimal brain function. Various factors, including vasodilators and vasoconstrictors, influence CBF and ICP by affecting the diameter of cerebral blood vessels.
**Why the Correct Answer is Right**
To answer this question correctly, we need to identify the agent that does not decrease CBF and ICP. **Option C** (Nicardipine) is a calcium channel blocker that causes vasodilation, leading to an increase in CBF and ICP. This is because calcium channels play a key role in the contraction of smooth muscle cells in blood vessels, and blocking these channels causes the vessels to relax and dilate.
**Why Each Wrong Option is Incorrect**
* **Option A:** (Hyperventilation) reduces CBF and ICP by causing vasoconstriction due to the decrease in carbon dioxide levels. This is because carbon dioxide is a potent vasodilator, and its decrease leads to a reduction in blood vessel diameter.
* **Option B:** (Nitroglycerin) causes vasodilation and a subsequent decrease in CBF and ICP due to its effect on nitric oxide production, which relaxes smooth muscle cells in blood vessels.
* **Option D:** (Ephedrine) increases CBF and ICP due to its sympathomimetic effects, which cause vasoconstriction and an increase in heart rate and cardiac output.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that hyperventilation can be used as a temporary measure to reduce ICP in cases of acute brain injury, but it should be used cautiously and monitored closely due to the risk of cerebral ischemia.
**Correct Answer:** C. Nicardipine.